Ligand’s Third Quarter Financial Results to be Reported October 30th
Go back to Ligand’s Third Quarter Financial Results to be Reported October 30th| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 285.60 -7.67 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $293.27 | 52 Week High | $139.79 | |||
| Open | $294.99 | 52 Week Low | $82.07 | |||
| Day High | $294.99 | P/E | 664.19 | |||
| Day Low | $285.24 | EPS | $0.43 | |||
| Volume | 67,947 | |||||

